Amgen OBU is so desperate

Discussion in 'Onyx Pharmaceuticals' started by Anonymous, Mar 1, 2015 at 7:42 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    And jealous that they wrote on the Takeda/Millenium board that they hope we fail. Don't they realize that if we fail, their stock options are worthless. We all know they want to be apart of our sales force.
     

  2. Anonymous

    Anonymous Guest

    Amgen folks were always losers. What did you expect from a primary care rep driven company.
     
  3. Anonymous

    Anonymous Guest

    We don't get stock options, we get RSUs. And you and your little drug are just a very small part of Amgen's portfolio.
     
  4. Anonymous

    Anonymous Guest

    you bought us. you obviously needed us as we were doing just fine independent before you.
     
  5. Anonymous

    Anonymous Guest

    Kyprolis is the only drug that's worth anything in the Amgen OBU of old and declining supportive care products. They couldn't even trust you losers to launch little Blincyto. They gave that to Onyx to get it launched correctly. Good luck in the pharma wasteland that is Thousand Oaks and the joke that is Amgen, where even physicians don't respect you. As amazing a drug as Kyprolis is, it can't save the rusty old sinking USS Amgen. Man the lifeboats! And when you need a job, the Onyx folks, who will gainfully employed where you're trying to get a job, will remember the unprofessionalism of our Amgen "colleagues" and return the favor by torpedoing you.